© All rights reserved. Powered by YOOtheme.

  • Sharing Knowledge
    Expertise
    Resources

  • Making Public Health Public

  • Premier Network of
    Public Health Communicators

  • Increasing the Dissemination of
    Accurate Information

LATEST NEWS HIGHLIGHTS

WHO Recommends New Name for Monkeypox Disease

Following a series of consultations with global experts, WHO will begin using a new preferred term “mpox” as a synonym for monkeypox. Both names will be used simultaneously for one year while “monkeypox” is phased out. When the outbreak of monkeypox expanded earlier this year, racist and stigmatizing language online, in other settings and in some communities was observed and reported to WHO. In several meetings, public and private, a number of individuals and countries raised concerns and asked WHO to propose a way forward to change the name. Learn more from WHO here.

December 1 is World AIDS Day

Thursday, December 1, is World AIDS Day and is an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV, and remember those who have died from an HIV-related illness. Started in 1988, World AIDS Day was the first-ever global health day. The CDC offers #MyVoiceMyAction, an initiative highlighting that every voice and every action impacts the global effort to stop the HIV epidemic. Communicators can make their voice heard and share others’ stories using the #MyVoiceMyAction World AIDS Day Toolkit.

Reaching Gen Z: Engaging Young Audiences in Public Health

ASTHO will host a virtual conversation on effective communication strategies for rebuilding trust in public health and engaging Gen Z as public health advocates. This virtual webinar on Monday, December 12, 2022 at 1:00 PM - 2:00 PM EST will detail the importance of public health messaging, social media, outreach and engagement and data; provide tips and advice for creating new or updating existing crisis communications plans; and share information on tools and resources to assist public health leaders and health communicators in combating misinformation and disinformation. Register here.

FEATURED TOPICS

Catch Anxiety Symptoms Early: National Recommendation to Screen Children Ages 8-18 

Written on


On October 11, 2022, the United States Preventive Services Task Force (USPSTF) recommended, for the first time, that children aged 8 and up should be screened for anxiety. This recommendation comes after the 2018-2019 National Survey of Children’s Health (NSCH) found that 7.8% of children and adolescents aged 3 to 17 years had a current anxiety disorder. 

The new recommendation applies to children who are not already diagnosed with a mental health condition and who don’t have recognized symptoms of anxiety, depression, or suicide. However, the USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety in children 7 years or younger. 

This is a very exciting recommendation since it is important to catch these conditions early because anxiety disorders in childhood and adolescence are associated with an increased likelihood of a future anxiety disorder or depression in adulthood. 

Though not a new recommendation, kids aged 12 and up should also be screened for depression, the task force advised, which is consistent with their findings in 2016. 

Before delving into the implications of USPSTF’s recommendations, it’s worth defining what anxiety is and its prevalence among children. 

Recent Developments in “Best Before” Food Labeling Practices 

Written on

You might be eyeing those strawberries in your refrigerator, but you don’t remember when you bought them. You look at the date on the packaging and notice that it has passed. Are the strawberries still safe to eat? You hate to waste what appears to be good food, but you also do not want you or your family to get sick. 

Like many people, you might be confused by the different “best before” or “use by” dates on many food items. Out of concern for your health, you might have thrown out food prematurely because of what looks like an “expiration” date. Unfortunately, misconceptions about these labels and fears of eating unhealthy foods contribute to U.S. households wasting an estimated 20% of their food each year. 

The Source of Confusion 

In the 1970s, food manufacturers began adding date labels to their products. While no regulations exist for these labels on most perishable foods, U.S. law requires that baby formula have “use by” dates. 

In 2019, the U.S. Food and Drug Administration (FDA) began an initiative to cut down on food waste. The primary problem stemmed from consumers throwing away food that was still safe because, according to the date labeling, such food appeared to “expire.” To help curb the waste, the FDA recommended that manufacturers use “best if used by” to indicate freshness and to label perishable foods with “use by” labeling. 

Research suggests that the wording of these labels makes a difference in how well consumers understand their meanings and how much food they unnecessarily throw out. Cornell University led a study finding that people interpret phrases like “use by” to relate solely to safety. In contrast, they view “best by” or “best if used by” as indicators of an item’s quality or freshness. According to the researchers, people are less likely to throw away food with “best by” labeling than “use by” terms. 

Ready or Not–Here It Comes: COVID-19 Public Health Emergency Declaration Expires Early in 2023 

Written on

President Biden’s COVID-19 public health emergency (PHE) declaration is ending soon and is not being renewed. The exact deadline is unclear—it may be as early as January or as late as April, but regardless the end of special pandemic accommodations is soon to be evaluated. The implications of the end of this declaration are enormous. 

There will be instances where new policies and procedures will remain in effect; however, there will be many instances where policies and procedures revert to the way they were before the pandemic. 

PHE declarations began in January 2020 and were eligible to be renewed every 90 days later. With the number of deaths per day holding steady at about 300—while still high, the Biden administration felt it was time to shift from a state of pandemic emergency and start to return to “normal.” 

However, while Biden is cautiously optimistic about COVID-19’s grip loosening, he still believes there needs to be targeted support to remain prepared and nimble if there is another outbreak of COVID-19 or one of its variants. As such, he has sent a $9.25 billion proposal to Congress for COVID-19 support. 

Below are some highlights of what’s included in the bill: 

  • $2.5 million "to ensure continued access to vaccines and therapeutics (including for the uninsured) as transition to commercialization of vaccines and therapeutics continues and for Strategic National Stockpile maintenance costs" 
  • $5 billion for "development of next-generation vaccines and therapeutics" 
  • $750 million for Long Covid research and treatment 
  • $1 billion in funding for the State Department to "provide support to prevent, detect, and respond to COVID-19 and other infectious diseases, including through vaccines, tests, and treatments, and through efforts to close gaps in routine immunizations” 

Marijuana Classification: The Stakes are “High”

Written on

On October 6, 2022, President Joe Biden pardoned all people convicted previously of federal offenses of simple marijuana possession. He encouraged state governors to do the same. 

Skeptical about whether marijuana should continue to be categorized as a Schedule I drug, the President asked the Secretary of Health and Human Services and the Attorney General to review the classification of marijuana. The Biden administration has not yet decided whether it plans on removing marijuana from the drug schedule entirely (de-scheduling) or placing it on a less-restrictive tier (rescheduling). 

Schedule I drugs have “no currently accepted medical use and a high potential for abuse.” LSD, ecstasy, and heroin are examples of Schedule I drugs. 

“The current classification of cannabis as a Schedule I drug doesn’t make sense. … It does have medicinal properties and a pretty low potential of abuse,” said Carrie Cuttler, Ph.D., an assistant professor of psychology at Washington State University and a researcher involved with the University’s Center for Cannabis Policy, Research, and Outreach. 

Let's explore the rationale for removing marijuana as a Schedule I drug and the pros/cons of rescheduling or de-scheduling it. 


Podcast

"Public Health Speaks"

A bi-monthly podcast series about public health issues to educate, inform and assist our members, partners and affiliate organizations in understanding and overcoming urgent communication challenges

From Our Partners


Get the App


© National Public Health Information Coalition (NPHIC).
All rights reserved.
Back to Top
greatplay.net güvenilir online bahis siteler 2022 jetbahis Rexbet hovarda mobilbahis güncel adres sartsız Deneme Bonus sekabet maltcasino güncel adres> pinbahis100.com betduman.com olabahis.top سایت شرط بندی shartkade.com 1xbet-mobil.com cialis cialis fiyat